ORIC Pharmaceuticals Inc (ORIC)
7.67
-0.41
(-5.07%)
USD |
NASDAQ |
Apr 25, 16:00
7.67
0.00 (0.00%)
After-Hours: 20:00
ORIC Pharmaceuticals Price to Book Value: 2.306 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.429 |
| April 23, 2024 | 2.637 |
| April 22, 2024 | 2.622 |
| April 19, 2024 | 2.763 |
| April 18, 2024 | 2.859 |
| April 17, 2024 | 2.934 |
| April 16, 2024 | 2.841 |
| April 15, 2024 | 2.868 |
| April 12, 2024 | 2.946 |
| April 11, 2024 | 3.007 |
| April 10, 2024 | 3.007 |
| April 09, 2024 | 3.208 |
| April 08, 2024 | 3.232 |
| April 05, 2024 | 3.298 |
| April 04, 2024 | 3.364 |
| April 03, 2024 | 3.425 |
| April 02, 2024 | 3.659 |
| April 01, 2024 | 3.888 |
| March 28, 2024 | 4.134 |
| March 27, 2024 | 4.048 |
| March 26, 2024 | 4.047 |
| March 25, 2024 | 4.047 |
| March 22, 2024 | 4.182 |
| March 21, 2024 | 4.387 |
| March 20, 2024 | 4.318 |
| Date | Value |
|---|---|
| March 19, 2024 | 4.306 |
| March 18, 2024 | 4.414 |
| March 15, 2024 | 4.540 |
| March 14, 2024 | 4.516 |
| March 13, 2024 | 4.579 |
| March 12, 2024 | 4.306 |
| March 11, 2024 | 4.507 |
| March 08, 2024 | 4.507 |
| March 07, 2024 | 4.784 |
| March 06, 2024 | 4.820 |
| March 05, 2024 | 4.657 |
| March 04, 2024 | 4.498 |
| March 01, 2024 | 4.387 |
| February 29, 2024 | 3.812 |
| February 28, 2024 | 3.516 |
| February 27, 2024 | 3.585 |
| February 26, 2024 | 3.576 |
| February 23, 2024 | 3.297 |
| February 22, 2024 | 3.028 |
| February 21, 2024 | 3.088 |
| February 20, 2024 | 3.136 |
| February 16, 2024 | 3.366 |
| February 15, 2024 | 3.366 |
| February 14, 2024 | 3.282 |
| February 13, 2024 | 3.375 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4212
Minimum
May 09 2022
7.683
Maximum
Dec 24 2020
2.238
Average
1.878
Median
Price to Book Value Benchmarks
| Geron Corp | 7.862 |
| Verastem Inc | 4.054 |
| Karyopharm Therapeutics Inc | -- |
| Syndax Pharmaceuticals Inc | 3.156 |
| Arvinas Inc | 3.259 |
Price to Book Value Related Metrics
| Price | 7.67 |
| Earnings Yield | -25.68% |
| Market Cap | 516.77M |